SIGN UP
LOG IN
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga·03/31/2025 17:05:39
Listen to the news
Gainers
- Corcept Therapeutics (NASDAQ:CORT) stock moved upwards by 88.8% to $103.12 during Monday's regular session. The market value of their outstanding shares is at $10.8 billion.
- Regencell Bioscience (NASDAQ:RGC) stock increased by 38.2% to $35.48. The company's market cap stands at $461.6 million.
- Citius Oncology (NASDAQ:CTOR) shares rose 34.34% to $0.89. The market value of their outstanding shares is at $63.9 million.
- bluebird bio (NASDAQ:BLUE) shares rose 26.41% to $5.16. The market value of their outstanding shares is at $50.2 million. The company's, Q4 earnings came out 2 days ago.
- WORK Medical Tech Gr (NASDAQ:WOK) shares moved upwards by 13.95% to $0.57. The company's market cap stands at $8.3 million.
- ABVC BioPharma (NASDAQ:ABVC) stock rose 13.34% to $0.97. The market value of their outstanding shares is at $23.0 million.
Losers
- Vaxcyte (NASDAQ:PCVX) shares declined by 46.9% to $36.92 during Monday's regular session. The company's market cap stands at $4.7 billion.
- Impact BioMedical (AMEX:IBO) shares fell 34.87% to $0.99. The market value of their outstanding shares is at $11.3 million.
- NewGenIvf Group (NASDAQ:NIVF) stock declined by 30.87% to $0.65. The company's market cap stands at $3.4 million.
- Taysha Gene Therapies (NASDAQ:TSHA) shares fell 30.06% to $1.35. The market value of their outstanding shares is at $276.7 million.
- Polyrizon (NASDAQ:PLRZ) shares declined by 27.49% to $0.35. The market value of their outstanding shares is at $1.5 million.
- Neurogene (NASDAQ:NGNE) shares decreased by 23.08% to $11.17. The market value of their outstanding shares is at $166.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.